De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial.Ma D, Price K, Moore E, et al. Lancet Oncol. 2025 Sep;26(9):1227-1239. doi: 10.1016/S1470-2045(…